The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 26, 2019

Filed:

Jan. 20, 2017
Applicant:

Sanofi-aventis Duetschland Gmbh, Frankfurt am Main, DE;

Inventors:

Ilona Eggert, Frankfurt am Main, DE;

Christopher Nigel Langley, Warwickshire, GB;

Shane Alistair Day, Warwickshire, GB;

Assignee:

Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 5/315 (2006.01); A61M 5/31 (2006.01); A61M 5/20 (2006.01); A61M 5/142 (2006.01); A61M 5/19 (2006.01); A61M 5/145 (2006.01); A61M 5/168 (2006.01); A61M 5/34 (2006.01); A61M 5/24 (2006.01); A61M 5/178 (2006.01);
U.S. Cl.
CPC ...
A61M 5/31546 (2013.01); A61M 5/14244 (2013.01); A61M 5/14566 (2013.01); A61M 5/16827 (2013.01); A61M 5/19 (2013.01); A61M 5/20 (2013.01); A61M 5/3146 (2013.01); A61M 5/345 (2013.01); A61M 2005/1787 (2013.01); A61M 2005/2407 (2013.01); A61M 2005/2474 (2013.01); A61M 2005/2496 (2013.01); A61M 2005/3118 (2013.01); A61M 2005/3128 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01);
Abstract

A medicament delivery device is shown for the administration of one or more drug agents. The device has a priming mode and a drug delivery mode for administering delivery of the one or more drug agents. The device comprises a controller configured to set the device in a priming mode when one or more predetermined states of the device are identified and to disable the drug delivery mode during said predetermined state(s). When states of the device are different from said predetermined states, the controller can set the device in the drug delivery mode. A priming mode may still be enabled through a user interface.


Find Patent Forward Citations

Loading…